Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397863 | 1.00 | CD81 (0.33) | CD81PTGS1AKR1C3 | |
| SCHEMBL304952 | 0.85 | CD81 (0.33) | CD81PTGS1AKR1C3 | |
| SCHEMBL669292 | 0.85 | CD81 (0.33) | CD81PTGS1AKR1C3 | |
| SCHEMBL15017599 | 0.83 | ALOX15 (0.37) | CD81PTGS1AKR1C3 | |
| SCHEMBL212197 | 0.83 | ALOX15 (0.37) | CD81PTGS1AKR1C3 | |
| SCHEMBL4085014 | 0.81 | TDP1 (0.36) | CD81PTGS1AKR1C3 | |
| SCHEMBL2119042 | 0.81 | CD81 (0.34) | CD81PTGS1AKR1C3 | |
| Methacrylic Acid SCHEMBL30704265 | 0.81 | ALOX15 (0.36) | CD81PTGS1AKR1C3 | |
| Methacrylic Acid SCHEMBL9931511 | 0.79 | ALOX15 (0.34) | CD81 | |
| SCHEMBL2727259 | 0.79 | ALDH1A1 (0.43) | CD81PTGS1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4706759-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTS | Aphaia Pharma AG (CH) | 2026-03-11 | — | — | EP | claimed |
| WO-2025119939-A1 | TREATMENT OF OBESITY AND RELATED CONDITIONS BY CIRCADIAN ADMINISTRATION OF ENTEROKINE-STIMULATING COMPOSITIONS | APHAIA PHARMA AG (CH) | 2025-06-12 | — | — | WO | claimed |
| EP-4164592-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTS | APHAIA IP AG (CH) | 2025-05-07 | — | — | EP | claimed |
| EP-3847220-B1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | claimed |
| WO-2024074802-A1 | SCRF COATINGS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2024-04-11 | — | — | WO | claimed |
| US-20240116037-A1 | SCRF COATINGS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2024-04-11 | — | — | US | claimed |
| EP-4349458-A1 | SCRF COATINGS | Johnson Matthey Public Limited Company (GB) | 2024-04-10 | — | — | EP | claimed |
| EP-3733721-B1 | PHOTOCURABLE ACRYLIC RESIN, ADHESIVE COMPOSITION COMPRISING SAME, AND ADHESIVE FILM FORMED BY USING SAME | LG CHEMICAL LTD (KR) | 2023-10-11 | — | — | EP | claimed |
| EP-3733807-B1 | ADHESIVE COMPOSITION AND PROTECTIVE FILM USING SAME | LG CHEMICAL LTD (KR) | 2023-09-06 | — | — | EP | claimed |
| US-20230233471-A1 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | APHAIA PHARMA AG (CH) | 2023-07-27 | — | — | US | claimed |
| EP-3666262-B1 | PHARMACEUTICAL ORAL DOSAGE FORMS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED DISEASES THROUGH ORCHESTRATED RELEASE OF ENTEROKINES | APHAIA IP AG (CH) | 2021-11-10 | — | — | EP | claimed |
| EP-3131396-B1 | PESTICIDAL TAPE FOR CONTROLLING CRAWLING PESTS | BASF SE (DE) | 2021-09-15 | — | — | EP | claimed |
| WO-2020120519-A1 | COMBINATORIAL ORAL TREATMENT OF METABOLIC DISORDERS THROUGH ORCHESTRATED RELEASE OF ENTEROKINES | APHAIA PHARMA AG (CH) | 2020-06-18 | — | — | WO | claimed |
| WO-2020120518-A1 | PHARMACEUTICAL ORAL DOSAGE FORMS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED DISEASES THROUGH ORCHESTRATED RELEASE OF ENTEROKINES | APHAIA PHARMA AG (CH) | 2020-06-18 | — | — | WO | claimed |
| EP-3666262-A1 | PHARMACEUTICAL ORAL DOSAGE FORMS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED DISEASES THROUGH ORCHESTRATED RELEASE OF ENTEROKINES | Aphaia Pharma AG (CH) | 2020-06-17 | — | — | EP | claimed |
| EP-1529787-B1 | Rosin-fatty acid ester vinylic polymers | MEADWESTVACO CORP (US) | 2006-03-15 | — | — | EP | claimed |
| EP-1215221-B1 | Rosin-fatty acid vinylic emulsion compositions | MEADWESTVACO CORP (US) | 2004-08-11 | — | — | EP | claimed |
| EP-0994123-B1 | Rosin-fatty acid vinylic polymer compositions | WESTVACO CORP (US) | 2004-06-30 | — | — | EP | claimed |
| EP-0884356-A2 | Blends of polyolefins and syndiotactic vinyl polymeres | PCD Polymere AG (AT) | 1998-12-16 | — | — | EP | claimed |
| EP-0590573-B1 | Resin for plastic lens | HITACHI CHEMICAL CO LTD (JP) | 1998-01-07 | — | — | EP | claimed |